Chinese expert consensus on endocrine therapy for breast cancer (2026 edition)
{{output}}
Background: Endocrine therapy (ET) is the primary treatment for hormone receptor (HR)-positive breast cancer. Based on the 2023 expert consensus, the Chinese Consensus Group on Breast Cancer Endocrine Therapy updated this consens... ...
